vs

Side-by-side financial comparison of FRANKLIN WIRELESS CORP (FKWL) and STANDARD BIOTOOLS INC. (LAB). Click either name above to swap in a different company.

STANDARD BIOTOOLS INC. is the larger business by last-quarter revenue ($19.6M vs $11.9M, roughly 1.6× FRANKLIN WIRELESS CORP). FRANKLIN WIRELESS CORP runs the higher net margin — 4.5% vs -177.4%, a 181.9% gap on every dollar of revenue. On growth, STANDARD BIOTOOLS INC. posted the faster year-over-year revenue change (-11.5% vs -33.1%). FRANKLIN WIRELESS CORP produced more free cash flow last quarter ($-4.1M vs $-23.1M). Over the past eight quarters, FRANKLIN WIRELESS CORP's revenue compounded faster (39.0% CAGR vs -12.2%).

Viaero Wireless is a regional wireless telecommunications company that provides direct coverage in Nebraska, eastern Colorado, western Kansas, and southeastern Wyoming. Based in Fort Morgan, Colorado, Viaero is often the primary cell tower owner in portions of its coverage area. Through roaming coverage partner relationships, Viaero customers can place and receive calls locally and across the country, internationally, and on cruise ships.

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

FKWL vs LAB — Head-to-Head

Bigger by revenue
LAB
LAB
1.6× larger
LAB
$19.6M
$11.9M
FKWL
Growing faster (revenue YoY)
LAB
LAB
+21.6% gap
LAB
-11.5%
-33.1%
FKWL
Higher net margin
FKWL
FKWL
181.9% more per $
FKWL
4.5%
-177.4%
LAB
More free cash flow
FKWL
FKWL
$19.0M more FCF
FKWL
$-4.1M
$-23.1M
LAB
Faster 2-yr revenue CAGR
FKWL
FKWL
Annualised
FKWL
39.0%
-12.2%
LAB

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
FKWL
FKWL
LAB
LAB
Revenue
$11.9M
$19.6M
Net Profit
$533.6K
$-34.7M
Gross Margin
17.1%
48.5%
Operating Margin
0.4%
-168.5%
Net Margin
4.5%
-177.4%
Revenue YoY
-33.1%
-11.5%
Net Profit YoY
133.3%
-28.8%
EPS (diluted)
$0.05
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FKWL
FKWL
LAB
LAB
Q4 25
$11.9M
Q3 25
$12.7M
$19.6M
Q2 25
$6.9M
$21.8M
Q1 25
$8.0M
$40.8M
Q4 24
$17.8M
Q3 24
$13.3M
$22.1M
Q2 24
$6.1M
$22.5M
Q1 24
$6.2M
$45.5M
Net Profit
FKWL
FKWL
LAB
LAB
Q4 25
$533.6K
Q3 25
$640.5K
$-34.7M
Q2 25
$-342.2K
$-33.5M
Q1 25
$-644.8K
$-26.0M
Q4 24
$228.7K
Q3 24
$515.2K
$-26.9M
Q2 24
$-1.8M
$-45.7M
Q1 24
$-1.2M
$-32.2M
Gross Margin
FKWL
FKWL
LAB
LAB
Q4 25
17.1%
Q3 25
22.8%
48.5%
Q2 25
18.0%
48.8%
Q1 25
16.9%
48.4%
Q4 24
18.2%
Q3 24
15.5%
54.9%
Q2 24
10.5%
46.1%
Q1 24
8.4%
53.1%
Operating Margin
FKWL
FKWL
LAB
LAB
Q4 25
0.4%
Q3 25
4.6%
-168.5%
Q2 25
-19.0%
-118.1%
Q1 25
-24.6%
-80.8%
Q4 24
4.5%
Q3 24
-2.8%
-120.9%
Q2 24
-36.7%
-134.5%
Q1 24
-25.2%
-132.2%
Net Margin
FKWL
FKWL
LAB
LAB
Q4 25
4.5%
Q3 25
5.0%
-177.4%
Q2 25
-4.9%
-153.7%
Q1 25
-8.1%
-63.8%
Q4 24
1.3%
Q3 24
3.9%
-122.0%
Q2 24
-28.9%
-203.3%
Q1 24
-19.0%
-70.6%
EPS (diluted)
FKWL
FKWL
LAB
LAB
Q4 25
$0.05
Q3 25
$0.05
$-0.09
Q2 25
$-0.03
$-0.09
Q1 25
$-0.05
$-0.07
Q4 24
$0.02
Q3 24
$0.04
$-0.07
Q2 24
$-0.16
$-0.12
Q1 24
$-0.10
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FKWL
FKWL
LAB
LAB
Cash + ST InvestmentsLiquidity on hand
$24.3M
$129.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$35.1M
$399.7M
Total Assets
$53.0M
$539.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FKWL
FKWL
LAB
LAB
Q4 25
$24.3M
Q3 25
$25.3M
$129.4M
Q2 25
$25.9M
$158.6M
Q1 25
$25.3M
$150.9M
Q4 24
$21.9M
Q3 24
$40.7M
$210.6M
Q2 24
$37.5M
$269.8M
Q1 24
$31.7M
$287.1M
Total Debt
FKWL
FKWL
LAB
LAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$55.2M
Q2 24
$55.1M
Q1 24
$55.0M
Stockholders' Equity
FKWL
FKWL
LAB
LAB
Q4 25
$35.1M
Q3 25
$35.1M
$399.7M
Q2 25
$34.5M
$424.5M
Q1 25
$35.3M
$454.6M
Q4 24
$36.0M
Q3 24
$35.8M
$489.3M
Q2 24
$35.1M
$510.3M
Q1 24
$36.9M
$577.3M
Total Assets
FKWL
FKWL
LAB
LAB
Q4 25
$53.0M
Q3 25
$53.3M
$539.6M
Q2 25
$51.3M
$557.0M
Q1 25
$49.7M
$579.6M
Q4 24
$54.5M
Q3 24
$51.6M
$681.5M
Q2 24
$46.7M
$708.7M
Q1 24
$50.0M
$777.7M
Debt / Equity
FKWL
FKWL
LAB
LAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.11×
Q2 24
0.11×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FKWL
FKWL
LAB
LAB
Operating Cash FlowLast quarter
$-4.1M
$-22.2M
Free Cash FlowOCF − Capex
$-4.1M
$-23.1M
FCF MarginFCF / Revenue
-34.3%
-118.1%
Capex IntensityCapex / Revenue
0.1%
4.5%
Cash ConversionOCF / Net Profit
-7.66×
TTM Free Cash FlowTrailing 4 quarters
$-9.2M
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FKWL
FKWL
LAB
LAB
Q4 25
$-4.1M
Q3 25
$-1.5M
$-22.2M
Q2 25
$2.3M
$-20.7M
Q1 25
$-5.9M
$-30.3M
Q4 24
$2.7M
Q3 24
$2.7M
$-27.9M
Q2 24
$6.2M
$-39.0M
Q1 24
$-779.0K
$-62.5M
Free Cash Flow
FKWL
FKWL
LAB
LAB
Q4 25
$-4.1M
Q3 25
$-1.5M
$-23.1M
Q2 25
$2.3M
$-22.6M
Q1 25
$-5.9M
$-35.3M
Q4 24
$2.7M
Q3 24
$2.6M
$-30.1M
Q2 24
$6.2M
$-41.0M
Q1 24
$-816.0K
$-63.3M
FCF Margin
FKWL
FKWL
LAB
LAB
Q4 25
-34.3%
Q3 25
-11.7%
-118.1%
Q2 25
33.6%
-103.6%
Q1 25
-73.7%
-86.6%
Q4 24
15.4%
Q3 24
19.9%
-136.4%
Q2 24
101.3%
-182.2%
Q1 24
-13.2%
-138.9%
Capex Intensity
FKWL
FKWL
LAB
LAB
Q4 25
0.1%
Q3 25
0.0%
4.5%
Q2 25
0.1%
8.7%
Q1 25
0.0%
12.4%
Q4 24
0.0%
Q3 24
0.2%
10.2%
Q2 24
0.0%
8.6%
Q1 24
0.6%
1.7%
Cash Conversion
FKWL
FKWL
LAB
LAB
Q4 25
-7.66×
Q3 25
-2.32×
Q2 25
Q1 25
Q4 24
11.99×
Q3 24
5.18×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FKWL
FKWL

Segment breakdown not available.

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

Related Comparisons